Down-regulation of DUSP6 expression in lung cancer: Its mechanism and potential role in carcinogenesis

American Journal of Pathology

Volumn 175, Issue 2, 2009, Pages 867-881

  Okudela, Koji ^a   Yazawa, Takuya ^a   Woo, Tetsukan ^a,b   Sakaeda, Masashi ^a   Ishii, Jun ^a   Mitsui, Hideaki ^a   Shimoyamada, Hiroaki ^a   Sato, Hanako ^a,c   Tajiri, Michihiko ^b   Ogawa, Nobuo ^b   Masuda, Munetaka ^a   Takahashi, Takashi ^d   Sugimura, Haruhiko ^e   Kitamura, Hitoshi ^a  

^a YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE 6; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; RETINOBLASTOMA PROTEIN; VIRUS ANTIGEN;

ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CELL IMMORTALIZATION; CELL LINE; CELL SUBPOPULATION; CELL SURVIVAL; DOWN REGULATION; EPITHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION; GENE LOCUS; GROWTH INHIBITION; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG CARCINOGENESIS; NEGATIVE FEEDBACK; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; UNINDEXED SEQUENCE; WESTERN BLOTTING;

EID: 68449086506     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080489     Document Type: Article

References (39)

1. Kitamura H, Kameda Y, Ito T, Hayashi H: Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma Am J Clin Pathol 2000, 113:610-620
2. Okudela K, Hayashi H, Ito T, Yazawa T, Suzuki T, Nakane Y, Sato H, Ishi H, KeQin X, Masuda A, Takahashi T, Kitamura H: K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinoma. Am J Pathol 2004, 164:91-100
3. Sharpless NE, DePinho RA: Telomeres, stem cells, senescence, and cancer. J Clin Invest 2004, 113:160-168
4. Sato M, Vaughan MB, Girard L, Peyton M, Lee W, Shames DS, Ramirez RD, Sunaga N, Gazdar AF, Shay JW, Minna JD: Multiple oncogenic changes (K-RAS (V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res 2006, 66:2116-2128
5. Li C, Scott DA, Hatch E, Tian X, Mansour SL: Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development. Development 2007, 134:167-176
6. Ekerot M, Stavridis MP, Delavaine L, Mitchell MP, Staples C, Owens DM, Keenan ID, Dickinson RJ, Storey KG, Keyse SM: Negative feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3gene promoter. Biochem 2008, 412:287-298
7. Muda M, Boschert U, Dickinson R, Martinou JC, Martinou I, Camps M, Schlegel W, Arkinstall S: MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J Biol Chem 1996, 271:4319-4326
8. Muda M, Theodosiou A, Rodrigues N, Boschert U, Camps M, Gillieron C, Davies K, Ashworth A, Arkinstall S: The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J Biol Chem 1996, 271:27205-27208
9. Keyse SM: Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev 2008, 27:253-261
10. Warmka JK, Mauro LJ, Wattenberg EV: Mitogen-activated protein kinase phosphatase-3 is a tumor promoter target in initiated cells that express oncogenic Ras. J Biol Chem 2004, 279:33085-33092
11. Owens DM, Keyse SM: Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene 2007, 26:3203-3213
12. Furukawa T, Yatsuoka T, Youssef EM, Abe T, Yokoyama T, Fukushige S, Soeda E, Hoshi M, Hayashi Y, Sunamura M, Kobari M, Horii A: Genomic analysis of DUSP6, a dual specificity MAP kinase phosphatase, in pancreatic cancer. Cytogenet Cell Genet 1998, 82:156-159
13. Furukawa T, Sunamura M, Motoi F, Matsuno S, Horii A: Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer. Am J Pathol 2003, 162:1807-1815
14. Furukawa T, Fujisaki R, Yoshida Y, Kanai N, Sunamura M, Abe T, Takeda K, Matsuno S, Horii A: Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasm's of the pancreas. Mod Pathol 2005, 18:1034-1042
15. Furukawa T: Molecular genetics of intraductal papillary-mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg 2007, 14:233-237
16. Xu S, Furukawa T, Kanai N, Sunamura M, Horii: A Abrogation of DUSP6 by hypermethylation in human pancreatic cancer. J Hum Genet 2005, 50:159-167
17. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chan WK, Li HN, Liu CC, Singh S, Chen WJ, Chen JJ, Yang PC: A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 2007, 356:11-20
18. Sato H, Yazawa T, Suzuki T, Shimoyamada H, Okudela K, Ikeda M, Hamada K, Yamada-Okabe H, Yao M, Kubota Y, Takahashi T, Kamma H, Kitamura H: Growth regulation via insulin-like growth factor binding protein-4 and -2 in association with mutant K-ras in lung epithelia. Am J Pathol 2006, 169:1550-1566
19. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng K, Finkbeiner WE, Widdicombe JH, Gruenert DC: CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 1994, 10:38-47
20. Masuda A, Kondo M, Saito T, Yatabe Y, Kobayashi T, Okamoto M, Suyama M, Takahashi T, Takahashi T: Establishment of human peripheral lung epithelial cell lines (HPL1) retaining differentiated characteristics and responsiveness to epidermal growth factor, hepatocyte growth factor, and transforming growth factor beta1. Cancer Res 1997, 57:4898-4904
21. Ward R, Hawkins N, O'Grady R, Sheehan C, O'Connor T, Impey H, Roberts N, Fuery C, Todd A: Restriction endonuclease-mediated selective polymerase chain reaction: a novel assay for the detection of K-ras mutations in clinical samples. Am J Pathol 1998, 153:373-379
22. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (Eds): World Health Organization Classification of Tumors. Pathology and Genetics of the Lung, Pleura, Thymus and Heart. IARC Press: Lyon 2004
23. Bermudez O, Marchetti S, Pagès G, Gimond C: Post-translational regulation of the ERK phosphatase DUSP6/MKP3 by the mTOR pathway. Oncogene 2008, 27:3685-3691
24. Marchetti S, Gimond C, Chambard JC, Touboul T, Roux D, Pouysségur J, Pagès G: Extracellular signal-regulated kinases phosphorylate mitogen-activated protein kinase phosphatase 3/DUSP6 at serines 159 and 197, two sites critical for its proteasomal degradation. Mol Cell Biol 2005, 25:854-864
25. Pierceall WE, Ananthaswamy HN: Transformation of NIH3T3 cells by transfection with UV-irradiated human c-Ha-ras-1 proto-oncogene DNA. Oncogene 1991, 6:2085-2091
26. Takiguchi Y, Takahashi Y, Kuriyama T, Miyamoto T: NIH3T3 transfectant containing human K-ras oncogene shows enhanced metastatic activity after in vivo tumor growth or co-culture with fibroblasts. Clin Exp Metastasis 1992, 10:351-360
27. Ohtani N, Zebedee Z, Huot TJ, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G, Hara E: Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 2001, 409:1067-1070
28. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW: Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997, 88:593-602
29. Marcotte R, and E. Wang: Replicative senescence revisited. J Gerontol A Biol Sci Med Sci 2002, 57:B257-B269
30. Sreeramaneni R, Chaudhry A, McMahon M, Sherr CJ, Inoue K: Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor. Mol Cell Biol 2005, 25:220-232
31. Zhang X, Kim J, Ruthazer R, McDevitt MA, Wazer DE, Paulson KE, Yee AS: The HBP1 transcriptional repressor participates in RAS-induced premature senescence. Mol Cell Biol 2006, 26:8252-8266
32. Huot TJ, Rowe J, Harland M, Drayton S, Brookes S, Gooptu C, Purkis P, Fried M, Bataille V, Hara E, Newton-Bishop J, Peters G: Biallelic mutations in p16 (INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts. Mol Cell Biol 2002, 22:8135-8143
33. Woo T, Okudela K, Yazawa T, Wada N, Ogawa N, Ishiwa N, Tajiri M, Rino Y, Kitamura H, Masuda M: Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas. Lung Cancer 2009, In Press
34. Shigematsu H, Gazdar AF: Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers. Int J Cancer 2006, 118:257-262
35. Speake G, Holloway B, Costello G: Recent developments related to the EGFR as a target for cancer chemotherapy. Curr Opin Pharmacol 2005, 5:343-349
36. Feig LA, Schaffhausen B: Signal transduction. The hunt for Ras targets. Nature 1994, 370:527-532
37. Esteller M: Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 2007, 16:R50-R59
38. Yang SH, Yates PR, Whitmarsh AJ, Davis RJ, Sharrocks AD: The Elk-1 ETS-domain transcription factor contains a mitogen-activated protein kinase targeting motif. Mol Cell Biol 1998, 18:710-720
39. Sharrocks AD: The ET: S-domain transcription factor family. Nat Rev Mol Cell Biol 2001, 2:827-837